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Transcriptional response in the unaffected kidney after con-
tralateral hydronephrosis or nephrectomy.
Background. Unilateral loss of kidney function is followed
by compensatory contralateral growth. The early, genome-wide
transcriptional response of the untouched kidney to unilat-
eral ureteral obstruction (UUO) or unilateral nephrectomy is
unknown.
Methods. Twelve adult male Sprague-Dawley rats were sub-
jected to UUO and twelve rats to unilateral nephrectomy. At
time points 12, 24, and 72 hours after insult four rats each were
sacrificed and the contralateral kidney harvested for genome-
wide gene expression analysis, transcription factor analysis, and
histomorphology.
Results. Microarray studies revealed that the majority of dif-
ferentially expressed transcripts were suppressed in UUO and
unilateral nephrectomy compared to control kidneys. The func-
tion of these suppressed genes is predominantly growth inhibi-
tion and apoptosis suggesting a net pro-hypertrophic response.
Insulin-like growth factor-2 (IGF-2)–binding protein was one
of the few activated genes. We observed a distinctly different
molecular signature between UUO and unilateral nephrectomy
at the three time points investigated. The early response in UUO
rats suggests a counterbalance to the nonfiltering kidney by acti-
vation of transport pathways such as the aquaporins. Unilateral
nephrectomy kidneys, on the other hand, respond immediately
to contralateral nephrectomy by activation of cell cycle regula-
tors such as the cyclin family. Several genes with weakly defined
function were found to be associated with either UUO or unilat-
eral nephrectomy. Transcription factor analysis of the identified
transcripts suggests common regulation at least of some of these
genes. All kidneys showed normal histology.
Conclusion. Release of growth inhibition by nephrectomy
leads to immediate cell cycle activation after unilateral nephrec-
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tomy, whereas UUO kidneys counterbalance filtration failure
by activation of several transporters.
Unilateral nephrectomy is followed by cellular growth
of the contralateral remaining kidney resulting in an early
reconstitution of the glomerular filtration rate (GFR) [1,
2]. However, little is known about the factors influencing
the compensatory increase of renal function and tissue in
the remaining kidney.
Previous work by Halliburton and Thomson [3] showed
that synthesis of RNA and DNA starts already 12 hours
after nephrectomy and remains in elevated state until suf-
ficient compensatory growth occurred. Several factors,
including endogenous hormones, and growth factors like
insulin-like growth factor-1 (IGF-1) were found to in-
fluence compensatory renal growth [4, 5]. After initially
transient proliferation, cellular hypertrophy is the main
compensatory response. Tubule cells increase in volume
and protein content and almost no proliferation occurs
after few days [6–8]. The finding of hypertrophy being
the predominant response to contralateral loss of func-
tion is supported by the nearly unchanged mitotic index
in the remaining kidney after unilateral nephrectomy.
Moskowitz and Liu [9] pointed out that compensatory
renal growth is negatively controlled. Proximal tubule
and peritubular endothelial cells are the main area of hy-
pertrophic growth [10, 11]. It has been shown that the
hypertrophic growth response is mediated in connection
to a cell cycle–dependent mechanism [12].
Although older studies revealed that transient hy-
dronephrosis does not alter metabolism and organ func-
tion in the affected kidney, little is known about the
response of the contralateral kidney [13]. It has been
reported that unilateral ureteral obstruction (UUO) is
associated with contralateral hyperplasia, while another
group demonstrated compensatory hypertrophy [14, 15].
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Since no clear target genes and metabolic pathways
are known that may be involved in the immediate regu-
lation of the compensatory growth response, we sought
to elucidate the molecular regulation of this process by
using an exploratory approach. Genome-wide gene ex-
pression analysis was used in rat models of UUO and
unilateral nephrectomy to identify potential differences
between UUO and unilateral nephrectomy in the con-
tralateral kidney and to compare these expression pro-
files to normal rat control kidneys.
METHODS
Animal model
Twenty-four adult male Sprague-Dawly rats (304 ±
22 g) were assigned randomly into two groups of 12 rats
each. Before surgery rats were anesthetized with pento-
barbital 60 mg/kg intraperitoneally and maintained on a
temperature-regulated operating table. Twelve animals
underwent unilateral nephrectomy of the right kidney
after the adrenal gland has been dissected free and was
left in place. On the remaining twelve rats of the other
group, ureteral ligation of the right kidney was performed
(UUO). Twelve kidneys of sham-operated adult male
Sprague-Dawly rats served as control. The postopera-
tive two-layer wound closure was sealed with Vicryl 3.0.
After 12, 24, and 72 hours the rats of both interven-
tion groups were sacrificed and the remaining kidney was
explanted under sterile conditions. Creatinine was mea-
sured from blood samples taken prior kidney explanta-
tion. The kidney was split longitudinally, one part was
immediately minced and submerged into RNAlaterTM
(Ambion, Austin, TX, USA) to prevent RNA degrada-
tion, the other was subjected to paraffin embedding [16].
The animal study was approved by the Austrian Federal
Ministry for Science, Section for Genetic Techniques and
Laboratory Animals (GZ 66.009/164-BrGt/2003 and GZ
66.009/250-BrGt/2003).
Sample preparation
Isolation of total RNA from homogenized kidneys
was performed by using Trizol (Invitrogen Corp.,
Carlsbad, CA, USA), mRNA was separated by Oligotex
mRNA Midi Kit (Qiagen, Hilden, Germany). Pooled
mRNA that was isolated from sham-operated rat kid-
neys was used as reference RNA. Quality of the iso-
lated total RNA was checked by gel electrophoresis
and with Agilent Bioanalyzer and RNA6000 LabChip
Kit (Agilent, Palo Alto, CA, USA). Sample and ref-
erence mRNA were labeled in a two-step proce-
dure with CyScribe cDNA postlabeling kit (Amersham
Pharmacia Biotech, Buckinghamshire, UK). Sample
preparation and hybridization was performed in random
order. Detailed protocols can be found on our website
(http://www.meduniwien.ac.at/nephrogene).
Microarray hybridization and scanning
Mouse cDNA microarrays holding 39958 cDNA fea-
tures were obtained from the Stanford University
Functional Genomics core facility. It has been shown
elsewhere that cross species hybridization of genes on
microarrays is feasible [17]. The experiment procedure
was performed as described previously [18]. Labeled sam-
ples were hybridized in Corning hybridization chambers
(Corning Inc., Corning, NY, USA) overnight in a wa-
ter bath (14 hours, 65◦C). Arrays were scanned with a
GenePix 4100A scanner (Axon Instruments, Union City,
CA, USA). Image griding and calculation of spot inten-
sity was performed using GenePix Pro 4.1 software.
Image-, grid-, and results files are stored at the Stanford
microarray database (http://genome-www4.stanford.
edu/MicroArray/SMD/) [19]. Information on samples,
material, experimental set-up, and procedures follows
MIAME guidelines (http://www.mged.org) to be found
at http://www.meduniwien.ac.at/nephrogene [20]. All
experimental, statistical and bioinformatics procedures
were performed in Vienna.
Data processing and statistical analysis
The data sets consist of 39958 cDNA features, of which
20769 are clones with Unigene symbol and nontrivial Uni-
gene title, 7538 have a Unigene symbol but a trivial Uni-
gene title, 3333 are clones with no Unigene symbol and
nontrivial Unigene title, and 7185 have no Unigene sym-
bol and trivial Unigene title [21]. Only spots with inten-
sities 1.2-fold over background in both channels 1 and 2
were used. In a first preprocessing step, a quality filter
was applied on the data set by considering only genes
and expressed sequence tags (ESTs) with at least 80% of
valid entries in the 24 array experiments. The remaining
missing values (3.9% of the whole data set) were sub-
stituted applying a k-nearest-neighbor algorithm, setting
the number of neighbors k to 10 [22]. To focus on differ-
entially regulated genes only those with at least 2 values
greater or equal an absolute log2 R/G value of 1 depicting
a twofold up- or down-regulation between sample RNA
and reference RNA remained in the data set. No correc-
tion for a putative batch bias was necessary because only
one array batch was used in the whole analysis for all 24
arrays. Ending up with a full data set consisting of 6763
genes and ESTs, a further preprocessing step was per-
formed. In each of the two groups (UUO and unilateral
nephrectomy) at every time point (12, 24, and 72 hours)
outliers were removed to obtain a SD value less than 1
for the particular gene [23].
The resulting genes were annotated with respect to
their molecular function, biologic processes, and cellular
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Table 1. Body weight and serum creatinine 12, 24, and 72 hours after unilateral ureteral obstruction (UUO) and unilateral nephrectomy
Body weight g Serum creatinine mg/dL
12 hours 24 hours 72 hours 12 hours 24 hours 72 hours
Unilateral nephrectomy 304 ± 12 293 ± 7 293 ± 10 0.65 ± 0.1 0.72 ± 0.08 0.6 ± 0.06
UUO 332 ± 21 302 ± 21 304 ± 17 0.71 ± 0.06 0.61 ± 0.05 0.62 ± 0.06
Data are mean ± SD.
locations using gene ontology terms from the Gene On-
tology Consortium [24]. The SOURCE tool from the
Stanford Genomics Facility was used to associate gene
ontology terms for the genes of interest [25].
An unsupervised hierarchical clustering algorithm was
applied for graphic representation of the differentially
expressed genes [26]. The Pearson r correlation coeffi-
cient was used as distance measure in the resulting den-
drograms and average linkage was used as linkage rule
in the cluster algorithm. Cluster analysis was performed
with the MultiExperiment Viewer (MeV) developed at
The Institute for Genomic Research (TIGR) [27].
Data were analyzed using SAS version 9.1.3 (SAS In-
stitute, Cary, NC, USA). Changes in body weight and
creatinine over time were analyzed by linear regression
analysis using dummy variables for the time points. An
unpaired t statistic of log-transformed expression values
was used to evaluate differences between UUO and uni-
lateral nephrectomy. No adjustment for multiple testing
was performed, because small differences in some tran-
script values might be functionally important as well and
thus should not be missed. Data are given as mean ± SD,
a P < 0.001 was considered statistically significant.
Promoter/transcription factor binding site
(TFBS) analysis
Promoter analysis was conducted on the resulting sets
of differentially expressed genes comparing the UUO
and the unilateral nephrectomy group. Gene symbols
could be assigned to 33 unique genes out of the 66 cDNA
features with 23 genes up-regulated in the UUO group
and 10 genes up-regulated in the unilateral nephrectomy
group.
The oPOSSUM database, a repository of transcription
factor binding sites in the regulatory regions of genes, was
used to find orthologous sequences as well as transcrip-
tion factors in the set of investigated genes [28]. Utilizing
the JASPAR database as repository for known TFBS the
sequences ranging from −5000 to +5000 bases with re-
spect to the transcription start site (TSS) of the target
genes were scanned for putative TFBS [29]. To reduce
the number of false positive hits, only those present in
the mouse as well as in the orthologous human sequence
were reported. To find these highly conserved regulatory
regions (phylogenetic footprints) between the human and
mouse genome the top 10% of conserved regions with a
minimum conservation level of 70% were analyzed for
TFBS. Of the 23 genes up-regulated in the UUO group
13 had an orthologous human mouse gene pair and could
be further analyzed. In the unilateral nephrectomy group,
seven out of the ten genes remained for further analysis.
Histomorphology
For histologic analysis 2 lm sections of formalin (4%,
neutrally buffered)-fixed paraffin embedded rat kidneys
were stained with hematoxylin and eosin and periodic
acid-Schiff (PAS). A semiquantitative scoring of vascular
and tubulointerstitial lesions was performed by H.R. who
was blinded for the type of intervention.
RESULTS
Kidney function after UUO and unilateral nephrectomy
Serum creatinine values and body weight of UUO and
unilateral nephrectomy animals at 12, 24, and 72 hours
after insult are depicted in Table 1. Creatinine and body
weight were unchanged over time in both groups.
Transcripts that are differentially regulated in both, UUO
and unilateral nephrectomy, compared to control rat
reference kidneys
Mean sector and printing plate analysis of variances
(ANOVAs) r2 were between 2 × 10−2 and 6 × 10−2 in
the microarray experiments suggesting no dependence
of results on spatial location or printing plate. The vast
majority of all features that were more than twofold
differentially expressed in both UUO and unilateral
nephrectomy vs. control kidney were suppressed at each
of the three time points (Table 2) (Web Fig. 1). Only three
out of the 101 sequences were more than twofold up-
regulated. Among the three is IGF-2 binding protein 1.
Interestingly, the majority of suppressed genes are in-
hibitors of growth, suggesting that compensatory growth
after UUO and unilateral nephrectomy is mediated by
silencing of antigrowth transcripts. The finding that tran-
scripts involved in protein degradation such as the ubi-
quitin pathway are suppressed as well, points into the
same direction. Furthermore, transcription factors re-
sponsible for growth inhibition such as “inhibitor of
growth family, member 4,” were suppressed as well. Ad-
ditionally, proapoptotic transcripts of enzymes such as
granzyme A are suppressed suggesting an indirect stim-
ulation of growth by a reduction of proapoptotic stimuli.
Finally, the anti-inflammatory response is mediated by
suppression of members of the complement cascade.
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Table 2. Functional roles of differentially regulated genes between unilateral ureteral obstruction (UUO) and unilateral nephrectomy versus
control at all three time points 12, 24, and 72 hours
Mean expression
UUO and unilateral
Accession nephrectomy at
number Gene name Gene symbol 12, 24, and 72 hours
Apoptosis
AA138788 Granzyme A Gzma −1.46
Cell cycle
BG065626 V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) Erbb3 −1.45
BG063022 Yamaguchi sarcoma viral (v-yes-1) oncogene homolog Lyn −1.41
BG064871 Lung carcinoma myc-related oncogene 1 Lmyc1 −1.23
Cytoskeleton
BG066664 CDNA sequence BC032204 BC032204 −1.69
BG067147 Dynamin binding protein Dnmbp −1.26
Immune response
BG066643 Complement component 4 binding protein C4bp −1.82
BG063898 Complement receptor-related protein Crry −1.44
Ion binding
AU040159 RIKEN cDNA 4732418C07 gene 4732418C07Rik −2.08
BG064367 Ectonucleoside triphosphate diphosphohydrolase 1 Entpd1 −1.74
BG066642 Cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1 Chordc1 −1.65
BG076243 Reticulocalbin 3, EF-hand calcium binding domain Rcn3 −1.59
Membrane
BG074161 RIKEN cDNA 2310075C12 gene 2310075C12Rik −1.56
BG065276 Podocalyxin-like Podxl −1.55
BG076282 Discoidin, CUB and LCCL domain containing 1 Dcbld1 −1.53
Metabolism
BG063893 SH3-binding kinase Sbk −1.84
BG063527 RAB geranylgeranyl transferase, b subunit Rabggtb −1.73
BG067167 Exonuclease 1 Exo1 −1.60
BG064371 Galactose-4-epimerase, UDP Gale −1.52
BG065124 Calcium activated nucleotidase 1 Cant1 −1.50
BG064066 ∗∗Phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma Pip5k1c −1.33
BG063506 Maternal embryonic leucine zipper kinase Melk −1.20
Protein modification
BG066359 Ubiquitin specific protease 1 Usp1 −1.99
BG070661 Procollagen, type IV, alpha 3 (Goodpasture antigen) binding protein Col4a3bp −1.93
BG066408 Dual specificity phosphatase 19 Dusp19 −1.76
BG066990 SUMO/sentrin specific protease 6 Senp6 −1.73
BG063225 Deltex 2 homolog (Drosophila) Dtx2 −1.43
Receptor
BG065542 Platelet derived growth factor receptor, alpha polypeptide Pdgfra −1.30
Signal transduction
BG065571 CD97 antigen Cd97 −1.77
BG063279 ADP-ribosylation factor-like 5 Arl5 −1.65
BG067803 Rap guanine nucleotide exchange factor (GEF) 5 Rapgef5 −1.43
Transcription
BG064651 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta Nfkbiz −2.26
BG066487 Musculin Msc −2.17
C79450 Inhibitor of growth family, member 4 Ing4 −2.05
C85178 Zinc finger protein 68 Zfp68 −1.71
BG065165 Thymopoietin Tmpo −1.65
BG065915 Ets variant gene 6 (TEL oncogene) Etv6 −1.58
BG066421 Necdin Ndn −1.57
C76795 Spi-C transcription factor (Spi-1/PU.1 related) Spic −1.44
Translation
BG063554 Eukaryotic translation initiation factor 1A Eif1a −1.24
Transport
BG066295 Transmembrane channel-like gene family 6 Tmc6 −1.99
BG066452 Trafficking protein particle complex 6B Trappc6b −1.99
C79033 Solute carrier family 34 (sodium phosphate), member 2 Slc34a2 −1.81
BG063793 Nucleoporin 93 Nup93 −1.58
BG066080 Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 Slc25a3 −1.50
BG068652 Karyopherin (importin) alpha 3 Kpna3 −1.45
BG066078 Syntaxin 3 Stx3 −1.31
Others
BG066902 RIKEN cDNA C530030P08 gene Fbxw11 1.52
BG063699 RAD1 homolog (S. pombe) Rad1 1.44
BG068632 Insulin-like growth factor 2, binding protein 1 Igf2bp1 1.16
Continued
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Table 2. continued
Mean expression
UUO and unilateral
Accession nephrectomy at
number Gene name Gene symbol 12, 24, and 72 hours
BG063823 Ubiquitin specific protease 8 Usp8 −2.53
BG075681 Transcribed locus −2.18
BG066367 DNA segment, Chr 11, ERATO Doi 707, expressed D11Ertd707e −2.15
BG064115 ∗∗CDNA sequence BC046331 BC046331 −2.07
BG064336 DNA2 DNA replication helicase 2-like (yeast) Dna2l −1.99
BG063272 RIKEN cDNA 5730472N09 gene 5730472N09Rik −1.92
BG066509 Pogo transposable element with KRAB domain D1Ertd251e −1.90
BG064669 Calmodulin regulated spectrin-associated protein 1 Camsap1 −1.85
BG063782 SMAD-specific E3 ubiquitin protein ligase 2 Smurf2 −1.84
BG065749 −1.77
BG066407 −1.75
BG064708 F-box and leucine-rich repeat protein 18 Fbxl18 −1.75
BG066389 A kinase (PRKA) anchor protein (yotiao) 9 Akap9 −1.73
BG064116 Axotrophin Axot −1.71
BG064705 RIKEN cDNA D630050G16 gene D630050G16Rik −1.70
BG066333 −1.67
BG063062 DNA segment, Chr 11, ERATO Doi 497, expressed D11Ertd497e −1.66
BG064402 RIKEN cDNA 1110034B05 gene 1110034B05Rik −1.63
BG070987 Gene model 1, (NCBI) −1.61
BG064464 RIKEN cDNA 2600005C20 gene 2600005C20Rik −1.58
BG064647 YEATS domain containing 2 Sumo2 −1.57
BG066405 Limb region 1 Lmbr1 −1.57
BG064347 Myeloid/lymphoid or mixed lineage-leukemia translocation to 6 homolog (Drosophila) AI315037 −1.56
BG064685 Queuine tRNA-ribosyltransferase domain containing 1 Qtrtd1 −1.56
C77431 RIKEN cDNA 4933412H03 gene 4933412H03Rik −1.56
BG063954 Translin Tsn −1.55
AA409791 Transcribed locus −1.51
BG065101 Expressed sequence AW320013 1700052N19Rik −1.51
BG063963 RIKEN cDNA 1500032H18 gene 1500032H18Rik −1.50
BG065887 −1.50
IW:598 −1.49
BG070155 CGG triplet repeat binding protein 1 Cggbp1 −1.49
BG065100 RIKEN cDNA 1110001C20 gene 1110001C20Rik −1.46
BG065037 Transmembrane protein 2 Tmem2 −1.45
BG063791 Mindbomb homolog 1 (Drosophila) Mib1 −1.44
BG067204 Expressed sequence C85492 C85492 −1.42
BG066510 RIKEN cDNA 2410003B16 gene 2410003B16Rik −1.41
BG065143 Zinc finger protein 94 Zfp94 −1.39
BG067950 RIKEN cDNA 4933428G09 gene 4933428G09Rik −1.38
BG064636 Phosphatidylinositol glycan, class S Pigs −1.33
BG066303 Expressed sequence AI450241 AI450241 −1.28
BG064169 RuvB-like protein 1 Ruvbl1 −1.27
BG067623 Transcribed locus −1.26
AW537825 RIKEN cDNA 2610033H07 gene 2610033H07Rik −1.26
BG063302 Expressed sequence AA408865 AA408865 −1.25
BG066505 Ring finger protein 20 Rnf20 −1.25
BG063884 RIKEN cDNA B230205O20 gene Wdr42a −1.20
The majority of transcripts were suppressed in UUO and unilateral nephrectomy compared to control. Numbers are log2 of expression values, resulting in negative
values for suppressed sequences and positive values for up-regulated features.
All these observations fit to the hypothesis that com-
pensatory renal growth in a situation of contralateral
insult is mediated by suppression of growth inhibitors
belonging to the main gene ontology terms of apoptosis,
metabolism, protein degradation, and inflammation.
Analysis of the regulation of transcripts that are dif-
ferentially regulated at all three time points in UUO
and unilateral nephrectomy separately changed the pic-
ture somehow (Web Table 1). Still the vast majority
of transcripts was suppressed in UUO and unilateral
nephrectomy compared to control kidney, but some ac-
tive growth regulators such as mitogen-activated pro-
tein kinases (MAPK) or IGF-2 could also be found
overexpressed.
Focusing on the sequential changes of transcripts over
the three time points in each group UUO and unilat-
eral nephrectomy separately, the picture became rather
complex. Still more transcripts were suppressed than
overexpressed, but the complexity of regulation of com-
pensatory growth became apparent. The hundreds of
more than twofold regulated genes and ESTs are dis-
played in Web Table 1 for all time points in each group.
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Fig. 1.
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Transcripts that are differentially regulated in UUO vs.
unilateral nephrectomy
Transcripts that are differentially regulated in UUO
and unilateral nephrectomy at each of the three time
points are displayed in Web Table 2. Only one transcript
could be identified that separated UUO and unilateral
nephrectomy in all three time points. At 12 hours genes
that were more than twofold up-regulated in UUO vs.
unilateral nephrectomy belong to the main functional
groups of transporters, metabolism, and membranes
(Table 3) (Fig. 1). Interestingly, genes that are involved in
urine concentration such as aquaporins or the solute car-
rier family were abundantly expressed in UUO compared
to unilateral nephrectomy. On the other hand, genes be-
longing to the cell cycle regulatory framework such as
cyclins were more abundantly expressed at 12 hours in
unilateral nephrectomy compared to UUO (Web Table 2)
(Fig. 1). At 24 hours, members of the transport gene on-
tology group such as “solute carriers” were more than
twofold up-regulated in UUO compared to unilateral
nephrectomy. In unilateral nephrectomy kidneys, how-
ever, only one cyclin and some few metabolism and mem-
brane genes were stronger expressed than in the UUO rat
kidneys (Web Table 2). At 72 hours after the contralateral
insult, UUO kidneys showed still up-regulation of solute
carriers compared to unilateral nephrectomy. Further-
more, genes belonging to the main gene ontology terms
of apoptosis, metabolism, protein modification, and some
others were abundantly expressed in UUO vs. unilateral
nephrectomy. In unilateral nephrectomy vs. UUO, how-
ever, only some membrane and metabolism genes were
abundantly expressed.
The complexity of the response in a healthy kidney
to contralateral injury can be appreciated by the many
different transcription patterns between UUO and uni-
lateral nephrectomy at the different time points inves-
tigated. No clear single hierarchical pathway could be
identified that separated the compensatory response in
the ipsilateral kidney after contralateral UUO or unilat-
eral nephrectomy.
Transcription factor analysis
Seven transcription factors with a significantly higher
number of binding sites compared to the reference data
set of all orthologous human/mouse gene pairs in the
oPOSSUM data base could be identified in the set of 23
genes up-regulated in the UUO group and are listed in
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 1. Expression profiles of differentially regulated genes at three time points (12, 24, and 72 hours) between unilateral ureteral obstruction (UUO)
and unilateral nephrectomy. White color represents suppressed genes/sequences compared to control and black color abundantly expressed features
over control. The unsupervised hierarchical cluster algorithm groups kidneys according to the similarity in their molecular signature next to each
other (1 to 3). Unilateral nephrectomy kidneys from the same time point as well as UUO kidneys from the same time group together. Shaded areas
represent other time points as the time indicated on the left. A heat map colored figure is available at: http://www.meduniwien.ac.at/nephrogene/data.
Web Table 3. Four of the seven transcription factors be-
long to the FORKHEAD class of transcription factors,
namely HFH-1 (Foxq1), HFH-2 (Foxd3), HFH-3 (Foxi1),
and HNF-3beta (Foxa2). E4BP4 (Nfil3) and Chop-cEBP
(Cebpa) are members of the bZIP class and Irf-1 (Irf1) is a
member of the TRP-CLUSTER of transcription factors.
A graphic representation of the genes holding binding
sites for at least one of the transcription factors can be
seen in Web Figure 2. Among the target genes are trans-
porters like Aqp11 and Slc38a2 as well as genes involved
in the immune system such as Bcl6 and Spata2.
No transcription factors with significantly higher num-
bers of binding sites in comparison to the reference
dataset could be obtained when analyzing the 10 genes
up-regulated in the unilateral nephrectomy group.
Histomorphology
By light microscopy renal histomorphology appeared
entirely normal in all treatment groups. Kidneys from
UUO or unilateral nephrectomy animals could not
be discriminated from sham-operated control animals
by histomorphologic criteria. In particular, there were
no morphologic signs of tubular injury in any of the
specimen.
DISCUSSION
In the present study we showed that contralateral
uninephrectomy or ureteral obstruction cause a dramatic
suppression of genes belonging to growth inhibition in
the ipsilateral, unaffected kidney within the first 3 days
after injury. Only few genes were overexpressed during
that time frame compared to control rat kidneys. Be-
sides the fact that gene expression profiles are different in
UUO and unilateral nephrectomy compared to control
rat kidneys, we also found distinctly different molecu-
lar signatures in UUO compared to unilateral nephrec-
tomy kidneys. UUO was associated with an activation of
genes belonging to the ontologies of transport, whereas
unilateral nephrectomy caused more activation of genes
involved in cell cycle and metabolism. The exact patho-
physiology behind the different response to UUO and
unilateral nephrectomy remains to be determined how-
ever. The variety of differentially regulated transcripts
belonging to various gene ontologies in UUO and uni-
lateral nephrectomy kidneys suggests a complex regula-
tion of the different responses. Possible pathophysiologic
mechanisms causing the observed molecular differences
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Table 3. Twofold or 0.5-fold differential regulation of genes in unilateral ureteral obstruction (UUO) versus unilateral nephrectomy
Mean Mean expression
Accession expression unilateral
number Gene name Gene symbol UUO nephrectomy
12 hours
Cytoskeleton
BG067867 Protein tyrosine phosphatase, nonreceptor type 14 Ptpn14 −0.90 0.31
Membrane
BG065334 Myristoylated alanine rich protein kinase C substrate Marcks −2.53 −1.08
Metabolism
BG075331 Myoinositol 1-phosphate synthase A1 Isyna1 0.20 −1.26
AV279051 Cytochrome P450, family 24, subfamily a, polypeptide 1 Cyp24a1 0.04 1.29
Transport
AU044566 ATPase, H+ transporting, V1 subunit D Atp6v1d 0.24 −0.96
AV030301 Trafficking protein particle complex 3 Trappc3 0.56 −0.70
AV074559 Aquaporin 11 Aqp11 1.16 0.03
AV028905 Solute carrier family 6 (neurotransmitter transporter, Slc6a12 1.67 0.09
betaine/GABA), member 12
BG074311 Glycine amidinotransferase Gatm −1.56 −0.28
(L-arginine:glycine amidinotransferase)
Others
BG063004 Lectin, galactose binding, soluble 1 Lgals1 −0.38 −1.77
AV071255 0.43 −1.22
AV085190 0.22 −1.13
410573 0.02 −1.05
IW:478 0.11 −1.02
AV087636 0.06 −0.97
AW550679 DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 Ddx27 0.31 −0.85
AV030530 0.38 −0.66
AV134036 0.81 −0.65
411377 0.44 −0.60
AV059177 Cystatin C Cst3 0.70 −0.51
AV093490 Expressed sequence AI316802 AI316802 0.86 −0.32
BG072110 Nuclear protein 1 Nupr1 1.68 0.42
BG066558 −2.84 −1.21
BG064705 RIKEN cDNA D630050G16 gene D630050G16Rik −2.49 −1.17
BG074321 CDNA sequence BC031601 BC031601 −1.37 −0.25
BG068368 −1.29 −0.20
BG071991 RIKEN cDNA 1110003E08 gene 1110003E08Rik −1.41 −0.20
BG073517 CD2-associated protein Cd2ap −1.31 0.01
IW:800 −1.12 0.31
BB569498 −0.66 0.56
AA189250 Small nuclear RNA activating complex, polypeptide 1 Snapc1 −0.12 0.91
24 hours cell cycle
AI385661 RIKEN cDNA 3110039M20 gene Foxg1 1.98 −0.33
Metabolism
AI838757 Monoamine oxidase A Maoa 0.68 −0.81
BG074100 Flavoprotein oxidoreductase MICAL3 Mical3 1.92 0.29
Transport
AV023118 RAB8A, member RAS oncogene family Rab8a 1.75 0.42
Others
BG065530 Zinc finger protein 54 Zfp54 −0.94 −2.70
BG065101 Expressed sequence AW320013 1700052N19Rik −1.14 −2.32
BG067782 RIKEN cDNA 1110008L16 gene 1110008L16Rik 1.49 −1.68
BG069653 Spermatogenesis associated 2 Spata2 −0.37 −1.65
AV029548 O-acetyltransferase Cast1 0.09 −1.37
412000 −0.19 −1.21
BG070308 Pellino 1 Peli1 −0.02 −1.18
AV049746 0.84 −1.12
AV032228 Solute carrier family 38, member 2 Slc38a2 1.02 −0.95
BG067593 0.34 −0.87
AV088090 1.43 −0.42
IW:242 1.25 −0.13
AV040804 1.78 −0.11
BG063121 2.05 0.01
AA408075 2.34 0.43
AI324741 Similar to Stefin homolog 1.90 0.47
AV088547 2.20 0.48
AI840913 1.78 0.54
Continued
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Table 3. continued
Mean Mean expression
Accession expression unilateral
number Gene name Gene symbol UUO nephrectomy
AI840593 1.89 0.59
BG062998 1.66 0.60
IW:720 2.29 0.60
AV078286 −1.25 −0.12
412724 −0.02 1.04
AV094711 RIKEN cDNA 2410002F23 gene 2410002F23Rik 0.32 1.34
72 hours Apoptosis
AA152673 B-cell leukemia/lymphoma 6 Bcl6 −0.20 −1.51
Others
BG066334 Hypothetical LOC380894 −0.74 −1.76
BG067947 Cysteine-rich motor neuron 1 Crim1 −0.22 −1.34
AV055887 0.65 −0.44
IW:601 −0.27 0.84
BG067498 −0.45 0.87
AV257618 0.02 1.06
All differences achieve a P value of < 0.001, no adjustment for multiple testing was performed. Numbers are log2 of expression values, resulting in positive values
for abundant expression and negative values for suppression in UUO and unilateral nephrectomy.
in responses to UUO and unilateral nephrectomy include
altered renal blood flow, different demands of solute ex-
cretion, or neuroendocrine crosstalk between kidneys.
It has been reported by Moskowitz et al [30] that in-
creased vasoconstriction in the renal cortex is among the
early events of compensatory hypertrophy after unilat-
eral nephrectomy. No such data, however, are available
for the UUO model. It may further be speculated that
hydronephrotic but perfused kidneys may release mes-
sengers into the blood stream causing contralateral ac-
tivation of potent solute carriers or vice versa that loss
of a growth inhibitor by unilateral nephrectomy cause
immediate hypertrophy.
The question of ipsilateral response to contralateral
nephrectomy has been studied previously. Liu and Preisig
[12] studied compensatory renal hypertophy within the
first 10 days after contralateral uninephrectomy in rats.
The authors were primarily interested whether the com-
pensatory growth was cell cycle dependent and used 5-
bromo-2′-deoxyuridine (BrdU) incorporation as marker
of hyperplasia while the protein to DNA content of prox-
imal tubules was used as marker of hypertrophy. Ac-
cording to our data the authors found that compensatory
growth after unilateral nephrectomy was caused by hy-
pertrophy and was cell cycle–dependent. The authors
found a late G1 arrest caused by cyclin D expression,
but insufficient activation of cyclin E, which is usually re-
quired for the cellular transition into the synthesis phase.
Mulroney and Pesce [31], on the other hand, showed
that compensatory hypertrophy after uninephrectomy in
adult male rats is growth hormone dependent but inde-
pendent of IGF-1. In juvenile rats, however, the authors
postulated the vice versa. We identified IGF-2 bind-
ing protein as one of the very few early continuously
up-regulated genes in both unilateral nephrectomy and
UUO. What that means in terms of regulation of early
compensatory growth by the IGF axis is unclear, given the
complex interplay of the IGF system. The IGFs comprise
an intricate regulation system with two growth factors,
cell-surface receptors, six high-affinity IGF binding pro-
teins and proteases, as well as other IGF binding protein
interacting molecules.
Besides expression of active growth regulators such as
IGF we observed suppressed protein degradation and in-
hibition of metabolism after contralateral injury. It has
been stated elsewhere that suppression of protein degra-
dation by regulation of ubiquitin ligases is mandatory
in compensatory hypertrophy of adult kidneys [32]. We
have shown in the present paper that several ubiquitin
proteases are suppressed at various time points in both
groups suggesting a key regulatory principle in compen-
satory growth after both types of unilateral injury.
Besides the known responses to uninephrectomy lit-
tle is known about transcriptional regulation of compen-
satory growth after UUO. We found mainly transcripts
belonging to the superfamilies of transporter and mem-
branes as well as metabolism abundantly expressed com-
pared to the unilateral nephrectomy group. One might
speculate that the nonfiltering but perfused kidney may
send some signal to the unaffected kidney causing tran-
scription of potent solute carriers and genes responsi-
ble for fluid regulation. Examples are the solute carrier
families 6, 7, 9, 25, 35, and 38 and aquaporins. It is impos-
sible, however, to speculate on the precise pathophysiol-
ogy of these early events since many covariates such as
antiduretic hormone levels and metabolism remain un-
known. Morishita et al [33] used knockout mice to eluci-
date the physiological role of aquaporin 11. Aquaporin
11–deficient mice showed abnormal tubule cell prolif-
eration and impaired basement membrane remodeling
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leading to severe disturbances in tubule fluid transport.
The vital importance of aquaporin 11 can be appreciated
by the fact that most of the mice died before weaning.
The identification of common transcription factors
in some of the differentially regulated genes between
UUO and unilateral nephrectomy suggests coregulation
of these transcripts. Overdier and colleagues showed that
HFH-3 (Foxi1) is expressed in the distal tubules of em-
bryonic and adult mouse kidneys. In their work they list
Na/K-ATPase, Na/H and anion exchangers, E-cadherin,
and mineralocorticoid receptor genes as target genes of
the transcription factor HFH-3 (Foxi1) [34]. Another
gene with a binding site for the HFH-3 (Foxi1) tran-
scription factor in the regulatory region and expressed
in renal tissue is the guanylyl cyclase/natriuretic peptide
receptor-A gene (Npr1), as reported by Garg et al [35].
Braam et al [36] report coordinated changes in genes of
the hepatocyte nuclear factor 3 family (NHF3, HNF3A,
HNF3B, and HNF3G), and the interferon regulatory fac-
tors IRF1 and IRF5 in proximal tubule cells in response
to angiotensin II.
Three of the seven transcription factors had at least
one cDNA clone spotted on the microarray but only one
(HFH-1) passed the preprocessing steps and could be
further analyzed. The other two (Chop-cEBP and Irf-1)
were excluded from analysis due to very low expression
levels. HFH-1 (Foxq1) was moderately higher expressed
in the UUO group as compared to the unilateral nephrec-
tomy group. As previously reported by Moscowitz et al
[30], the coordinate expression of genes involved in com-
pensatory hypertrophy is mediated by the differential
regulation of both, growth inducing and repressing tran-
scription factors. Among these transcription factors was
cyclin D which was also identified as being up-regulated
12 hours after unilateral nephrectomy compared to sham
in our data. Other genes that were identified as rele-
vant for compensatory growth by Moskowitz et al such as
actin, heat shock proteins, and Na/K-ATPases were also
found to be activated after unilateral nephrectomy in our
analysis (Web Table 1).
CONCLUSION
We have shown that unilateral nephrectomy or hy-
dronephrosis cause a set of transcriptional modifications
in the unaffected contralateral kidney which is regu-
lated at least in part by a set of few transcription fac-
tors. The response to UUO is fundamentally different
than to unilateral nephrectomy. UUO is more associated
with molecular signatures of solute and fluid transport as
well as metabolism and membrane transport, whereas
unilateral nephrectomy leads to an immediate hyper-
trophic response caused by cell cycle regulators such as
cyclins and by suppression of growth inhibitors. Based on
our exploratory data deductive studies may be designed
that seek to elucidate the exact pathophysiologic differ-
ences of compensatory growth after UUO or unilateral
nephrectomy.
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